Meta-analyses of antiepileptic drugs for refractory partial (focal) epilepsy: an observation.
作者信息
Brodie Martin J
机构信息
Epilepsy Unit, Western Infirmary, Glasgow, UK.
出版信息
Br J Clin Pharmacol. 2013 Nov;76(5):630-1. doi: 10.1111/bcp.12176.
Abstract
摘要
相似文献
1
Meta-analyses of antiepileptic drugs for refractory partial (focal) epilepsy: an observation.抗癫痫药物治疗难治性部分性（局灶性）癫痫的荟萃分析：一项观察
Br J Clin Pharmacol. 2013 Nov;76(5):630-1. doi: 10.1111/bcp.12176.
2
Network meta-analysis and the comparison of efficacy and tolerability of anti-epileptic drugs for treatment of refractory focal epilepsy.网络荟萃分析及抗癫痫药物治疗难治性局灶性癫痫的疗效与耐受性比较
Br J Clin Pharmacol. 2013 Nov;76(5):827-8. doi: 10.1111/bcp.12175.
3
Newer drugs for focal epilepsy in adults.成人局灶性癫痫的新型药物
BMJ. 2012 Jan 26;344:e345. doi: 10.1136/bmj.e345.
4
[Main factors determining the choice of antiepileptic drugs in a polytherapy regime in adult patients and specifics of the treatment of focal epilepsy with some new medications].[成人患者联合治疗方案中抗癫痫药物选择的主要决定因素以及某些新型药物治疗局灶性癫痫的特点]
Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(10 Pt 2):35-43.
5
Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses.抗癫痫药物治疗局灶性癫痫患者的疗效和耐受性：系统评价与网状Meta分析
Pharmacotherapy. 2016 Dec;36(12):1255-1271. doi: 10.1002/phar.1855.
6
Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: reply to Costa et al.新型抗癫痫药物在难治性部分性癫痫中的临床可比性：对科斯塔等人的回复
Epilepsia. 2011 Nov;52(11):2139-41. doi: 10.1111/j.1528-1167.2011.03285.x.
7
[Efficacy and safety of a new antiepileptic drug lacosamide in patients with focal epilepsy: data of double-blind placebo controlled trials].新型抗癫痫药物拉科酰胺治疗局灶性癫痫患者的疗效与安全性：双盲安慰剂对照试验数据
Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(3 Suppl 2):39-43.
8
Emerging drugs for partial onset seizures.部分发作性癫痫的新兴药物。
Expert Opin Emerg Drugs. 2010 Sep;15(3):415-31. doi: 10.1517/14728214.2010.492394.
9
[Treatment protocol for long-term anti-epilepsy drugs in adults with refractory partial epilepsy].[成人难治性部分性癫痫长期抗癫痫药物治疗方案]
Rev Neurol (Paris). 2004 Jun;160 Spec No 1:5S252-64.
10
[Antiepileptic drugs--therapeutical update 2012].
MMW Fortschr Med. 2012 Apr 19;154(7):74-8.
引用本文的文献
1
Safety and Tolerability of Lacosamide in Patients With Epilepsy: A Systematic Review and Meta-Analysis.拉科酰胺在癫痫患者中的安全性和耐受性：一项系统评价和荟萃分析。
Front Pharmacol. 2021 Sep 20;12:694381. doi: 10.3389/fphar.2021.694381. eCollection 2021.
2
Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta-analyses and real-world evidence on antiepileptic drugs.理解局灶性癫痫比较有效性研究的挑战：抗癫痫药物的网络荟萃分析和真实世界证据综述。
Epilepsia. 2020 Apr;61(4):595-609. doi: 10.1111/epi.16476. Epub 2020 Mar 22.
3
Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data.吡仑帕奈治疗难治性局灶性癫痫患者的两年真实世界经验：奥地利的数据。
Ther Adv Neurol Disord. 2016 Nov;9(6):445-453. doi: 10.1177/1756285616661115. Epub 2016 Sep 1.
4
Perampanel for focal epilepsy: insights from early clinical experience.吡仑帕奈治疗局灶性癫痫：早期临床经验的见解
Acta Neurol Scand. 2016 Mar;133(3):160-72. doi: 10.1111/ane.12529. Epub 2015 Oct 28.
5
Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective.药物难治性局灶性癫痫中抗癫痫药物疗效和耐受性的网状荟萃分析：临床视角
Eur J Clin Pharmacol. 2014 Jun;70(6):647-54. doi: 10.1007/s00228-014-1669-y. Epub 2014 Mar 28.
本文引用的文献
1
Early predictors of outcome in newly diagnosed epilepsy.新诊断癫痫的预后早期预测因素。
Seizure. 2013 Jun;22(5):333-44. doi: 10.1016/j.seizure.2013.02.002. Epub 2013 Apr 11.
2
Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials.抗癫痫药物治疗难治性局灶性癫痫的疗效和耐受性比较：系统评价与网状Meta分析显示需要进行长期对照试验。
Br J Clin Pharmacol. 2013 Nov;76(5):649-67. doi: 10.1111/bcp.12083.
3
Patterns of treatment response in newly diagnosed epilepsy.新诊断癫痫的治疗反应模式。
Neurology. 2012 May 15;78(20):1548-54. doi: 10.1212/WNL.0b013e3182563b19. Epub 2012 May 9.
4
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.药物难治性癫痫患者健康相关生活质量的决定因素：一项大型多中心研究的结果，该研究连续纳入了使用经过验证的定量评估方法的患者。
Epilepsia. 2011 Dec;52(12):2181-91. doi: 10.1111/j.1528-1167.2011.03325.x.
5
Clinical comparability of the new antiepileptic drugs in refractory partial epilepsy: a systematic review and meta-analysis.新抗癫痫药物在难治性部分性癫痫中的临床可比性：系统评价和荟萃分析。
Epilepsia. 2011 Jul;52(7):1280-91. doi: 10.1111/j.1528-1167.2011.03047.x. Epub 2011 Apr 19.
6
Modern antiepileptic drug development has failed to deliver: ways out of the current dilemma.现代抗癫痫药物的开发未能成功：摆脱当前困境的出路。
Epilepsia. 2011 Apr;52(4):657-78. doi: 10.1111/j.1528-1167.2011.03024.x. Epub 2011 Mar 22.
7
Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta-analysis.影响抗癫痫药物反应的因素：随机对照试验的系统回顾和荟萃分析。
Epilepsia. 2011 Feb;52(2):219-33. doi: 10.1111/j.1528-1167.2010.02915.x. Epub 2011 Jan 26.
8
Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.耐药性癫痫的定义：国际抗癫痫联盟治疗策略特别工作组的共识提案。
Epilepsia. 2010 Jun;51(6):1069-77. doi: 10.1111/j.1528-1167.2009.02397.x. Epub 2009 Nov 3.
9
Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis.现代抗癫痫药物治疗耐药性癫痫的安慰剂校正疗效：系统评价和荟萃分析。
Epilepsia. 2010 Jan;51(1):7-26. doi: 10.1111/j.1528-1167.2009.02299.x. Epub 2009 Sep 10.
10
Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs.新型抗癫痫药物随机附加试验中的无癫痫发作结局
Epilepsia. 2007 Jul;48(7):1303-7. doi: 10.1111/j.1528-1167.2007.01136.x. Epub 2007 May 23.
Zotero 插件